高级检索

    地佐辛应用于肥胖患者无痛结肠镜检查的安全性与有效性研究

    Application of dizocine for painless colonoscopy in obese patients: safety and effectiveness

    • 摘要: 目的 观察在无痛结肠镜检查中,地佐辛联合丙泊酚对肥胖患者呼吸抑制的影响。方法 将92例肥胖患者随机分为地佐辛组(D组)和对照组(C组),分别给予0.05 mg/kg地佐辛(稀释至5 ml)或5 ml生理盐水,5 min后静脉注射2 mg/kg丙泊酚,丙泊酚4 mg· kg-1· h-1泵注用于麻醉维持。主要观察指标为患者脉搏氧饱和度(SpO2)下降的次数,次要观察指标为呼吸暂停发作次数、第1次SpO2下降的时间和丙泊酚总消耗量。同时观察意识丧失时间、苏醒时间、术后Ramsay评分、麻醉恢复室(PACU)的停留时间、VAS评分、内镜医师和患者的满意度及呼吸循环抑制等不良事件。结果 2组患者人口统计学特征的差异无统计学意义。与C组比较,D组患者检查时呼吸暂停发作次数降低,SpO2下降次数降低,丙泊酚用量减少,意识丧失时间和苏醒时间缩短,在PACU停留时间短,VAS评分降低,内镜医师及患者满意度增高,差异有统计学意义(P<0.05或P<0.01)。Kaplan-Meier曲线显示,D组患者第1次SpO2下降的中位时间(71.5 s)比C组(53.5 s)长,差异有统计学意义(P<0.01)。2组术后Ramsay评分、不良事件发生率的差异无统计学意义(P>0.05)。结论 地佐辛联合丙泊酚用于无痛结肠镜检查可以降低肥胖患者SpO2下降次数和呼吸暂停发作次数,提高患者麻醉安全性。

       

      Abstract: Objective To observe the effect of dizocine combined with propofol on respiratory depression in obese patients undergoing painless colonoscopy. Methods A total of 92 obese patients were randomly divided into two groups: a dizocine group (Group D) and a control group (Group C). They were administered with 0.05 mg/kg dizocine (diluted to 5 ml) or 5 ml normal saline, before intravenous injection of 2 mg/kg propofol 5 min later. Propofol was pumped at 4 mg· kg-1· h-1 for anesthesia maintenance. The primary outcomes were the number of times oxygen saturation(SpO2) decreased. The secondary outcomes were the number of apnea episodes, the time of the first hypoxia episode and the total consumption of propofol. Meanwhile, unconsciousness time, the time of recovery, postoperative Ramsay score, the length of post-anesthesia care unit (PACU) stay, VAS score, endoscopist and patient satisfaction and adverse events like respiratory recycle inhibition were observed. Results There were no statistical difference in demographic characteristics between the two groups. Compared with group C, group D showed decreases in the number of apnea episodes, the number of times SpO2 decreased, the amount of propofol used, the time of unconsciousness and the time of recovery, the length of PACU stay, and VAS scores, as well as improvement in endoscopist and patient satisfaction (P<0.05 orP<0.01). According to the Kaplan-Meier curve, the median time of the first hypoxia attack in group D (71.5 s) was significantly longer than that in group C (53.5 s) (P<0.01). There was no significant difference in Ramsay score and adverse event rate between the two groups (P>0.05).Conclusions The combined use of dezocine and propofol for painless colonoscopy can reduce the number of times SpO2 declines and apnea in obese patients, and improve the safety of anesthesia.

       

    /

    返回文章
    返回